PASADENA, Calif.--(BUSINESS WIRE)-- An interview with Dr. Sam Stupp, founder and scientific advisor to Nanotope, Inc., an Arrowhead (NASDAQ: ARWR) portfolio company, was broadcast by the BBC World Service on November 28, 2010. In the interview, Dr. Stupp describes and discusses the regenerative medicine platform being developed by Nanotope, as well as nanotechnology and regenerative medicine in general.
About Arrowhead Research Corporation
Arrowhead Research Corporation (www.arrowheadresearch.com) (NASDAQ: ARWR) is a nanotechnology company commercializing new technologies in the areas of life sciences and electronics. Arrowhead is seeking to build value for shareholders through the progress of its subsidiaries and investments. Currently, Arrowhead is focused primarily on its two majority owned subsidiaries; Unidym, a leader in carbon nanotube technology for electronic applications, and Calando, at the forefront of clinical application of RNAi delivery technology. Arrowhead also has minority investments in two privately held nanobiotech companies, Nanotope, Inc. and Leonardo Biosystems, Inc.
The Piacente Group
Brandi Floberg, 212-481-2050
KEYWORDS: United States North America California
INDUSTRY KEYWORDS: Technology Nanotechnology Health Biotechnology Research Science General Health